Dr. Harnick Dhillon, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $972.27 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $350.01 | 6 | $0 (2023) |
| ABBVIE INC. | $196.88 | 8 | $0 (2024) |
| PFIZER INC. | $195.94 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $64.46 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $55.85 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.38 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.31 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $22.46 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $16.89 | 1 | $0 (2022) |
| Lilly USA, LLC | $13.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.79 | 14 | PFIZER INC. ($97.16) |
| 2023 | $469.23 | 14 | E.R. Squibb & Sons, L.L.C. ($240.31) |
| 2022 | $70.16 | 4 | PFIZER INC. ($34.20) |
| 2021 | $22.46 | 1 | Merck Sharp & Dohme Corporation ($22.46) |
| 2020 | $90.63 | 1 | E.R. Squibb & Sons, L.L.C. ($90.63) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/03/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2023 | AbbVie Inc. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/29/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $132.19 | General |
| Category: Cardiovascular | ||||||
| 11/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $1.65 | General |
| Category: Cardiovascular | ||||||
| 10/26/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/21/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/25/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.61 | General |
| Category: Cardiovascular | ||||||
| 08/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: DIABETES | ||||||
| 08/01/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 482 | 749 | $182,559 | $69,255 |
| 2022 | 10 | 678 | 1,242 | $261,838 | $88,482 |
| 2021 | 7 | 682 | 1,209 | $245,805 | $81,979 |
| 2020 | 8 | 625 | 1,096 | $205,914 | $67,963 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 112 | 262 | $53,993 | $23,461 | 43.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 140 | 144 | $55,532 | $18,191 | 32.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 104 | 197 | $33,700 | $11,667 | 34.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 101 | 105 | $21,398 | $9,213 | 43.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 41 | $17,936 | $6,723 | 37.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 208 | 590 | $118,000 | $30,709 | 26.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 140 | 144 | $46,800 | $20,790 | 44.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 83 | 209 | $47,025 | $15,851 | 33.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 148 | 155 | $27,900 | $12,215 | 43.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 15 | 15 | $4,875 | $2,048 | 42.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 65 | $5,200 | $1,944 | 37.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $3,393 | $1,554 | 45.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 16 | 27 | $3,375 | $1,296 | 38.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 13 | 13 | $2,795 | $1,112 | 39.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,475 | $963.42 | 38.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 254 | 683 | $136,600 | $36,477 | 26.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 181 | 192 | $34,560 | $15,078 | 43.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 81 | $26,325 | $12,477 | 47.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 62 | 135 | $30,375 | $10,638 | 35.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 53 | 54 | $12,150 | $5,343 | 44.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 38 | 49 | $3,920 | $1,290 | 32.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 15 | 15 | $1,875 | $675.36 | 36.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 237 | 624 | $124,800 | $33,843 | 27.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 198 | 209 | $37,620 | $16,821 | 44.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 62 | $13,950 | $4,936 | 35.4% |
About Dr. Harnick Dhillon, MD
Dr. Harnick Dhillon, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1114336724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harnick Dhillon, MD has received a total of $972.27 in payments from pharmaceutical and medical device companies, with $319.79 received in 2024. These payments were reported across 34 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($972.27).
As a Medicare-enrolled provider, Dhillon has provided services to 2,467 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $307,679. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Syracuse, NY
- Active Since 08/07/2014
- Last Updated 01/06/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1114336724
Products in Payments
- ELIQUIS (Drug) $412.11
- CAMZYOS (Drug) $133.84
- TEFLARO (Drug) $100.23
- DALVANCE (Drug) $75.93
- ENTRESTO (Drug) $64.46
- XARELTO (Drug) $55.85
- JARDIANCE (Drug) $40.40
- NINLARO (Drug) $29.38
- VERQUVO (Drug) $22.46
- AVYCAZ (Drug) $20.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syracuse
Seokhyun Jin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,625
Dr. Avneet Singh, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $16,015
Dr. Rebecca Jameson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,760
Nelson Sofoluke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,288
Dr. Tarek Ibrahim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,187
Dr. David Padalino, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,144